Akın Özdemir

Dr. Akın Özdemir

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
AÖAkın Özdemir
Akın Özdemir
AYAyşe Mine Yılmaz
Ayşe Mine Yılmaz
HÖHafize ÖZTÜRK ÖZENER
Hafize ÖZTÜRK ÖZENER
Squalene, a natural isoprenoid and an intermediate in cholesterol synthesis, has anti-inflammatory and skin-protective effects. The aim of the present stud

24 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
AÖAkın Özdemir
Akın Özdemir
MSMehmet Altay Sevimay
Mehmet Altay Sevimay
EKErcan KARAKAŞ
Ercan KARAKAŞ
Background/Objectives: Oral healthcare succeeds not only when treatment is biologically sound but when its outcome meets patient expectations, making expectation management a measurable component of care quality. Patient satisfaction in dental implant therapy is strongly influenced by pre-treatment expectations, yet differences between patient expectations and dentists’ perceptions of those expectations remain poorly characterized. This study compared the two using a mirror-design survey. Methods: A cross-sectional survey was administered to adult patients (n = 250) and dentists involved in implant therapy (n = 200). A 16-item questionnaire was developed in two parallel versions covering two domains, outcome expectations and surgical process apprehension, rated on a 5-point Likert scale. Internal consistency, item- and subscale-level differences, and signed and absolute between-group difference scores were analyzed. Results: Significant between-group differences were identified in 13 of the 16 items, while total scale scores did not differ between groups, producing a cancel-out effect at the aggregate level. Within the surgical process apprehension domain, patients were more optimistic than dentists perceived, with procedural pain showing the largest between-group difference (Cliff’s δ = 0.437). The opposite pattern emerged for long-term outcomes, where concern about implant loss yielded the largest difference across the entire instrument (δ = 0.645). Dentists’ clinical experience was negatively correlated with the signed total gap score (ρ = −0.342, p < 0.001), indicating reduced directional bias among more experienced clinicians. Conclusion: Patients’ expectations differed systematically from dentists’ perceptions of those expectations across both domains, but these opposing differences offset at the aggregate level. Aggregate summary scores may therefore obscure clinically relevant item-level differences, and directional item-level analyses may better capture expectation patterns in implant dentistry.

11 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
AÖAkın Özdemir
Akın Özdemir
AYAli Yüncü
Ali Yüncü
AYAyşe Mine Yılmaz
Ayşe Mine Yılmaz
HÖHafize ÖZTÜRK ÖZENER
Hafize ÖZTÜRK ÖZENER
Background/Objectives: Chronic hyperglycemia drives gingival fibroblast dysfunction, disrupting extracellular matrix homeostasis and the migratory capacity required for wound healing, which contributes to increased periodontal susceptibility in diabetes. Ferulic acid (FA), a dietary phenolic compound with antioxidant and anti-inflammatory properties, has demonstrated wound-healing activity in various tissues; however, its effects on human gingival fibroblasts (HGFs) under hyperglycemic conditions remain unclear. This study investigated the effects of FA on HGF viability, wound closure, and the secreted concentrations of matrix metalloproteinase-1 (MMP-1), tissue inhibitor of metalloproteinase-1 (TIMP-1), and interleukin-6 (IL-6) under normoglycemic and hyperglycemic conditions. Methods: Cultured HGFs (HGF-1 cell line) were pre-conditioned for 72 h under normal glucose (5.5 mM) or high glucose (25 mM), with an iso-osmolar mannitol control to distinguish glucose-specific effects from osmotic changes. Viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and wound closure by scratch assay following FA treatment, while MMP-1, TIMP-1, and IL-6 concentrations in conditioned medium were quantified by enzyme-linked immunosorbent assay (ELISA). Results: FA was non-cytotoxic at all tested concentrations, whereas 50 µM transiently increased viability. FA significantly enhanced wound closure under both conditions, independent of osmotic effects. High glucose increased IL-6 concentration in the conditioned medium (significant at 48 h) and MMP-1 levels. FA partially attenuated MMP-1 levels at specific time points, modestly reduced IL-6 levels, and markedly increased TIMP-1 concentration under both glucose conditions. Conclusions: FA enhanced wound closure in scratch assay and shifted the secreted MMP-1/TIMP-1 concentration ratio toward a more favorable, matrix-protective profile at the protein level, without cytotoxicity, supporting further investigation of its potential role in periodontal tissue repair under high glucose conditions.